These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32162577)

  • 1. GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion.
    Cai YQ; Hou YY; Pan ZZ
    Mol Pain; 2020; 16():1744806920911543. PubMed ID: 32162577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.
    Hou YY; Cai YQ; Pan ZZ
    Neuroscience; 2020 Feb; 426():141-153. PubMed ID: 31863796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nanoparticles (Ag-NPs) in the central amygdala protect the rat conditioned by morphine from withdrawal attack due to naloxone via high-level nitric oxide.
    Rahimpour M; Karami M; Haeri Rohani A
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):857-866. PubMed ID: 31897505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala.
    Hou YY; Cai YQ; Pan ZZ
    J Neurosci; 2015 Feb; 35(8):3689-700. PubMed ID: 25716866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.
    Russell SE; Puttick DJ; Sawyer AM; Potter DN; Mague S; Carlezon WA; Chartoff EH
    J Neurosci; 2016 May; 36(21):5748-62. PubMed ID: 27225765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure.
    Jin C; Araki H; Nagata M; Suemaru K; Shibata K; Kawasaki H; Hamamura T; Gomita Y
    Psychopharmacology (Berl); 2004 Oct; 175(4):428-35. PubMed ID: 15175841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central amygdala GluA1 facilitates associative learning of opioid reward.
    Cai YQ; Wang W; Hou YY; Zhang Z; Xie J; Pan ZZ
    J Neurosci; 2013 Jan; 33(4):1577-88. PubMed ID: 23345231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
    Gracy KN; Dankiewicz LA; Koob GF
    Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal.
    Wang L; Shen M; Jiang C; Ma L; Wang F
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27385383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
    Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
    Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.
    Zhang Z; Tao W; Hou YY; Wang W; Lu YG; Pan ZZ
    Neuropsychopharmacology; 2014 Aug; 39(9):2263-71. PubMed ID: 24686896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAA receptors are involved in the analgesic effects of morphine microinjected into the central nucleus of the amygdala.
    Rashvand M; Khajavai A; Parviz M; Hasanein P; Keshavarz M
    Clin Exp Pharmacol Physiol; 2014 May; 41(5):338-44. PubMed ID: 24606334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
    Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
    Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corydaline and l-tetrahydropalmatine attenuate morphine-induced conditioned place preference and the changes in dopamine D
    Jiang WN; Jing X; Li M; Deng H; Jiang T; Xiong KZ; Chen Y; Wang XF; Wang QJ
    Eur J Pharmacol; 2020 Oct; 884():173397. PubMed ID: 32717192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.